A Shannon entropy analysis of immunoglobulin and T cell receptor
Molecular Immunology, ISSN: 0161-5890, Vol: 34, Issue: 15, Page: 1067-1082
1997
- 141Citations
- 94Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations141
- Citation Indexes141
- 141
- CrossRef121
- Captures94
- Readers94
- 94
Article Description
In 1970, before any antigen-bound immunoglobulin structure had been solved, Elvin Kabat proposed that regions of high amino acid diversity would be the antigen binding sites of immunoglobulin (Kabat, 1970). Conversely, sites of low variability were proposed to be structural, framework regions. This variability was defined by Wu and Kabat as the number of different amino acids found at a site divided by the relative frequency of the most common amino acid at that site (Wu and Kabat, 1970). Several groups have subsequently devised improvements of Kabat-Wu variability analysis (Litwin and Jores, 1992). While these methods are somewhat better than Kabat Wu, they still suffer from Kabat-Wu's basic limitation: they account for only the most common one or two amino acids in estimating diversity. This leads to underestimates of low diversities and exaggerations of high diversities. Shannon information analysis eliminates serious bias and is more stable than Kabat-Wu and second generation measures of diversity (Jores et al. 1990; Wu and Kabat 1970). Statistical reliability can be measured using Shannon analysis, and Shannon measurements can be provided with error estimates. Here we use Shannon's method to analyze the amino acid diversity at each site of T cell receptor V α and V β to identify complementarity determining regions and framework sites. Our results reveal that the T cell receptor is significantly more diverse than immunoglobulin-suggesting T cell receptor has more than the previously-discovered four complementarity determining regions. These new complementarity determining regions may represent a larger antigen combining site, additional combining sites, or an evolutionary strategy to avoid inappropriate interaction with other molecules
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0161589097001302; http://dx.doi.org/10.1016/s0161-5890(97)00130-2; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0031427052&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9519765; https://linkinghub.elsevier.com/retrieve/pii/S0161589097001302; http://linkinghub.elsevier.com/retrieve/pii/S0161589097001302; http://api.elsevier.com/content/article/PII:S0161589097001302?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0161589097001302?httpAccept=text/plain; http://dx.doi.org/10.1016/s0161-5890%2897%2900130-2; https://dx.doi.org/10.1016/s0161-5890%2897%2900130-2
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know